Sugi Predict

Sugi Predict / Compounds / SCHEMBL7182837

SCHEMBL7182837

SCHEMBL7182837

CCCCC(CC)C[PH](=O)c1ccccc1C(=O)c1c(C)cc(C)cc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.43
▸ CA2 P00918 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ LMNA P02545 2/20 0.40
▸ PRSS1 P07477 1/20 0.39
▸ PRSS2 P07478 1/20 0.39
▸ PRSS3 P35030 1/20 0.39
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ HPGD P15428 2/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ TSHR P16473 2/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ CRHR1 P34998 3/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ MCOLN3 Q8TDD5 1/20 0.34
▸ HTT P42858 2/20 0.34
▸ BCL2L1 Q07817 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ PYGL P06737 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7185607 0.91 ALDH1A1 (0.44) ALDH1A1CA2CYP3A4LMNAPRSS1
SCHEMBL7177163 0.90 ALDH1A1 (0.40) ALDH1A1CA2CYP3A4LMNAPRSS1
SCHEMBL7174990 0.89 ALDH1A1 (0.44) ALDH1A1CA2CYP3A4LMNAPRSS1
SCHEMBL7188888 0.84 ALDH1A1 (0.40) ALDH1A1CA2CYP3A4LMNAPRSS1
SCHEMBL7181140 0.83 ALDH1A1 (0.43) ALDH1A1CA2CYP3A4LMNAPRSS1
SCHEMBL7180875 0.82 ALDH1A1 (0.43) ALDH1A1CA2CYP3A4LMNAPRSS1
SCHEMBL7182222 0.81 CA2 (0.44) ALDH1A1CA2CYP3A4LMNAPRSS1
SCHEMBL7189803 0.81 ALDH1A1 (0.41) ALDH1A1CA2CYP3A4LMNAPRSS1
SCHEMBL1138265 0.79 KMT2A (0.42) ALDH1A1LMNAMEN1KMT2AHPGD
SCHEMBL7182745 0.77 ALDH1A1 (0.41) ALDH1A1CA2CYP3A4LMNAPRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 — — US disclosed
US-20020107413-A1 Organometallic monoacylarylphosphines WOLF JEAN-PIERRE (CH) 2002-08-08 — — US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 — — US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107413-A1 Organometallic monoacylarylphosphines CBR1, NAF1, DHCR24 ALDH1A1 3416/4885CA2 2297/4885CYP3A4 1652/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 ALDH1A1 3984/4885CA2 2346/4885CYP3A4 1881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.